GW Pharmaceuticals plc
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 38 (Table of Contents)
Published: 3 Jul-2003
DOI: 10.3833/pdr.v2003.i38.887 ISSN: 1756-7874
Section: Company Profile
Abstract
GW Pharmaceuticals (GW) develops medicines derived from the cannabis plant that have the potential to treat a plethora of disorders including pain and spasm in multiple sclerosis, spinal cord injury, neuropathic pain, arthritis, stroke and head injury, AIDS, nausea, migraine and cancer pain...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS